Supplementation with Folic Acid and Cardiovascular Outcomes in End-Stage Kidney Disease: A Multi-Institution Cohort Study.
Yi-Ran TuKun-Hua TuCheng-Chia LeePei-Chun FanChieh-Li YenVictor Chien-Chia WuJi-Tseng FangYung-Chang ChenPao-Hsien ChuChih-Hsiang ChangPublished in: Nutrients (2022)
a daily 5 mg folic acid supplementation might result in a lower event rate of arteriovenous access thrombosis in patients with ESKD than weekly folic acid supplementation. Further prospective studies are warranted to explore the preventive effect of folate on thrombosis.
Keyphrases